Zdzislaw M. Szulc

Zdzislaw M. Szulc

Auto-generated profile, based on publicly available information

Zdzislaw M. Szulc

Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA

Research Focus & Metrics

Academic Career Length

49Years (1978-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2006 in Methods
Verified
Journal Article
Closed access
JBJacek Bielawski
Jacek Bielawski
ZSZdzislaw M. Szulc
Zdzislaw M. Szulc
YHYusuf A. Hannun
Yusuf A. Hannun
ABAlicja Bielawska
Alicja Bielawska

25 November 2012 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
SSSahar A. Saddoughi
Sahar A. Saddoughi
SGSalih Gencer
Salih Gencer
YPYuri K. Peterson
Yuri K. Peterson
KWKatherine E. Ward
Katherine E. Ward
AMArchana Mukhopadhyay
Archana Mukhopadhyay
BOBesim Ogretmen
Besim Ogretmen
Mechanisms that alter protein phosphatase 2A (PP2A)‐dependent lung tumour suppression via the I2PP2A/SET oncoprotein are unknown. We show here that the tumour suppressor ceramide binds I2PP2A/SET selectively in the nucleus and including its K209 and Y122 residues as determined by molecular modelling/simulations and site‐directed mutagenesis. Because I2PP2A/SET was found overexpressed, whereas ceramide was downregulated in lung tumours, a sphingolipid analogue drug, FTY720, was identified to mimick ceramide for binding and targeting I2PP2A/SET, leading to PP2A reactivation, lung cancer cell death, and tumour suppression in vivo . Accordingly, while molecular targeting of I2PP2A/SET by stable knockdown prevented further tumour suppression by FTY720, reconstitution of WT‐I2PP2A/SET expression restored this process. Mechanistically, targeting I2PP2A/SET by FTY720 mediated PP2A/RIPK1‐dependent programmed necrosis (necroptosis), but not by apoptosis. The RIPK1 inhibitor necrostatin and knockdown or genetic loss of RIPK1 prevented growth inhibition by FTY720. Expression of WT‐ or death‐domain‐deleted (DDD)‐RIPK1, but not the kinase‐domain‐deleted (KDD)‐RIPK1, restored FTY720‐mediated necroptosis in RIPK1 −/− MEFs. Thus, these data suggest that targeting I2PP2A/SET by FTY720 suppresses lung tumour growth, at least in part, via PP2A activation and necroptosis mediated by the kinase domain of RIPK1.

6 August 2009
Verified
Book Chapter
Closed access
PDF file
JBJacek Bielawski
Jacek Bielawski
JPJason S. Pierce
Jason S. Pierce
JSJustin Snider
Justin Snider
BRBarbara Rembiesa
Barbara Rembiesa
ZSZdzislaw M. Szulc
Zdzislaw M. Szulc
ABAlicja Bielawska
Alicja Bielawska

1 January 2010
Verified
Book Chapter
Closed access
PDF file
JBJacek Bielawski
Jacek Bielawski
JPJason S. Pierce
Jason S. Pierce
JSJustin Snider
Justin Snider
BRBarbara Rembiesa
Barbara Rembiesa
ZSZdzislaw M. Szulc
Zdzislaw M. Szulc
ABAlicja Bielawska
Alicja Bielawska

12 April 2007 in Cancer Chemotherapy and Pharmacology
Verified
Journal Article
Closed access
PDF file
DHDavid H. Holman
David H. Holman
LTLorianne S. Turner
Lorianne S. Turner
AEAhmed El-Zawahry
Ahmed El-Zawahry
SESaeed Elojeimy
Saeed Elojeimy
XLXiang Liu
Xiang Liu
JNJames S. Norris
James S. Norris

1 January 1979 in Synthesis
Verified
Journal Article
Closed access
PDF file
LSLudwik Syper
Ludwik Syper
KKKrystian Kloc
Krystian Kloc
JMJacek Młochowski
Jacek Młochowski
ZSZdzisław Szulc
Zdzisław Szulc